Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

UK regulatory approval for SCIB1 phase II advanced melanoma trial

pharmatimesApril 28, 2019

Tag: SCIB1 phase II , UK , melanoma trial

PharmaSources Customer Service